Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
LKN
0.00%
0.0¢
LUKIN RESOURCES LIMITED - Corporate Spotlight
Currently unlisted.
Proposed listing date: TBA
Add to my watchlist
No Corporate Spotlight currently available.